The COVID-19 pandemic has and continues to change attitudes towards leadership, crisis management, and collaboration. We spoke to several thought leaders who shared with us their experience of navigating operations through a changing landscape as well as their hopes for the future – conversations that you can find below. But beyond COVID-19 there are other areas of unmet need that the industry is working to address. We've highlighted two of them: the development of drugs for rare diseases and non-alcoholic steatohepatitis.

 
ADVANCED MEDICINE
Leadership in Times of Crisis
03/04/2021 | Stephanie Vine
Experts from our previous Power Lists discuss the challenges of leadership during these trying times.
DRUG DISCOVERY
No Longer Overlooked
02/26/2021 | Maryam Mahdi
Ensuring that options for patients living with rare diseases aren’t scarce.
DRUG DISCOVERY
Breaking a Therapeutic Curse
02/18/2021 | Grit Zahn
New approaches are underway for treating nonalcoholic steatohepatitis.
BUSINESS PRACTICE
COVID-19: A Year of Unprecedented Change
03/01/2021 | Maryam Mahdi
What role have small molecules played in the fight against COVID-19?
 
White Papers
Development of Nasal Spray Medications

Droplet size impacts how an active ingredient is deposited in the nasal cavity and therefore how well it is absorbed by the body. Read more

Theory and Practice of Differential Scanning Calorimetry

Differential scanning calorimetry (DSC) is an analytical technique with a proven track record for biomolecular stability studies. The benefits and specifics of DSC are discussed. Read More.

 
Product Profile
Crystallisation provides the first-choice opportunity to innovative particle design

Crystallisation is a key unit operation in manufacturing APIs. Learn more about crystallisation development in all stages of the drug development pipeline in this insightful white paper by Johnson Matthey. Read more

 
Special Promotions
HOW can you safely package your sensitive drugs in a glass vial?

Now’s your chance to find out. At the SCHOTT Pharma world of innovations. Explore 2 new innovation rooms & interact with the SCHOTT Experts via live chat. Join the online exhibition from Mar 08.-12.!

Small Molecule Market Opportunities, Challenges, and More

Thought leaders from Cambrex discuss market opportunities for small molecules, the drug development challenges of hydrates, best practices for pediatric medicines, and more in this eBook.

 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.

Find out more